Cargando…

Efficacy of Extracorporeal Shock Wave Lithotripsy in Pediatric and Adolescent Urolithiasis

PURPOSE: To retrospectively evaluate the efficacy of extracorporeal shock wave lithotripsy (ESWL) by age and current condition as a first-line treatment for pediatric and adolescent urolithiasis. MATERIALS AND METHODS: The computerized records of 55 children were retrospectively reviewed from March...

Descripción completa

Detalles Bibliográficos
Autores principales: Jee, Joon Yeop, Kim, Soo Dong, Cho, Won Yeol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866291/
https://www.ncbi.nlm.nih.gov/pubmed/24363869
http://dx.doi.org/10.4111/kju.2013.54.12.865
_version_ 1782296142076182528
author Jee, Joon Yeop
Kim, Soo Dong
Cho, Won Yeol
author_facet Jee, Joon Yeop
Kim, Soo Dong
Cho, Won Yeol
author_sort Jee, Joon Yeop
collection PubMed
description PURPOSE: To retrospectively evaluate the efficacy of extracorporeal shock wave lithotripsy (ESWL) by age and current condition as a first-line treatment for pediatric and adolescent urolithiasis. MATERIALS AND METHODS: The computerized records of 55 children were retrospectively reviewed from March 1991 to July 2007. The children were below 18 years of age and had undergone ESWL monotherapy for urolithiasis. There were 36 boys (65.5%) and 19 girls (34.5%), with a mean age of 8.5 years (range, 0.5-18 years). There were 24 patients aged 7 years or less and 31 patients aged more than 7 years. RESULTS: The mean size of the stones was 9.48 mm (range, 4-22 mm). The overall success rate of ESWL was 90.9% (50 children). The mean number of ESWL sessions was 2.02 (range, 1-10). The mean number of ESWL sessions for the patient group aged 7 years or less was 1.16 (range, 1-2) and that for the patient group aged more than 7 years was 2.97 (range, 1-10; p=0.037). There was also a statistically significant difference in the mean number of ESWL sessions between the younger and older patients who needed general anesthesia (1.16 vs. 2.2 sessions, respectively; 0.042). CONCLUSIONS: In the patient group aged 7 years or less, the number of ESWL sessions and the complication rate were comparable with those for endoscopic management. Thus, ESWL is an effective first-line treatment modality for patients aged less than 7 years.
format Online
Article
Text
id pubmed-3866291
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher The Korean Urological Association
record_format MEDLINE/PubMed
spelling pubmed-38662912013-12-20 Efficacy of Extracorporeal Shock Wave Lithotripsy in Pediatric and Adolescent Urolithiasis Jee, Joon Yeop Kim, Soo Dong Cho, Won Yeol Korean J Urol Original Article PURPOSE: To retrospectively evaluate the efficacy of extracorporeal shock wave lithotripsy (ESWL) by age and current condition as a first-line treatment for pediatric and adolescent urolithiasis. MATERIALS AND METHODS: The computerized records of 55 children were retrospectively reviewed from March 1991 to July 2007. The children were below 18 years of age and had undergone ESWL monotherapy for urolithiasis. There were 36 boys (65.5%) and 19 girls (34.5%), with a mean age of 8.5 years (range, 0.5-18 years). There were 24 patients aged 7 years or less and 31 patients aged more than 7 years. RESULTS: The mean size of the stones was 9.48 mm (range, 4-22 mm). The overall success rate of ESWL was 90.9% (50 children). The mean number of ESWL sessions was 2.02 (range, 1-10). The mean number of ESWL sessions for the patient group aged 7 years or less was 1.16 (range, 1-2) and that for the patient group aged more than 7 years was 2.97 (range, 1-10; p=0.037). There was also a statistically significant difference in the mean number of ESWL sessions between the younger and older patients who needed general anesthesia (1.16 vs. 2.2 sessions, respectively; 0.042). CONCLUSIONS: In the patient group aged 7 years or less, the number of ESWL sessions and the complication rate were comparable with those for endoscopic management. Thus, ESWL is an effective first-line treatment modality for patients aged less than 7 years. The Korean Urological Association 2013-12 2013-12-10 /pmc/articles/PMC3866291/ /pubmed/24363869 http://dx.doi.org/10.4111/kju.2013.54.12.865 Text en © The Korean Urological Association, 2013 http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Jee, Joon Yeop
Kim, Soo Dong
Cho, Won Yeol
Efficacy of Extracorporeal Shock Wave Lithotripsy in Pediatric and Adolescent Urolithiasis
title Efficacy of Extracorporeal Shock Wave Lithotripsy in Pediatric and Adolescent Urolithiasis
title_full Efficacy of Extracorporeal Shock Wave Lithotripsy in Pediatric and Adolescent Urolithiasis
title_fullStr Efficacy of Extracorporeal Shock Wave Lithotripsy in Pediatric and Adolescent Urolithiasis
title_full_unstemmed Efficacy of Extracorporeal Shock Wave Lithotripsy in Pediatric and Adolescent Urolithiasis
title_short Efficacy of Extracorporeal Shock Wave Lithotripsy in Pediatric and Adolescent Urolithiasis
title_sort efficacy of extracorporeal shock wave lithotripsy in pediatric and adolescent urolithiasis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866291/
https://www.ncbi.nlm.nih.gov/pubmed/24363869
http://dx.doi.org/10.4111/kju.2013.54.12.865
work_keys_str_mv AT jeejoonyeop efficacyofextracorporealshockwavelithotripsyinpediatricandadolescenturolithiasis
AT kimsoodong efficacyofextracorporealshockwavelithotripsyinpediatricandadolescenturolithiasis
AT chowonyeol efficacyofextracorporealshockwavelithotripsyinpediatricandadolescenturolithiasis